Quarterly Report

Processa Pharmaceuticals, Inc. Filed 2026-05-07 Acc 0001493152-26-021721

Documents 1

2026-08-14 10-Q Quarterly Report
2026-05-07 10-Q Quarterly Report
2026-05-01 4 Pres. Research & Development bought 1,706 shares at $2.69 ($4,589)
2026-05-01 4 Chief Financial Officer bought 2,190 shares at $2.69 ($5,891)
2026-05-01 4 Chief Executive Officer bought 2,034 shares at $2.69 ($5,471)
2026-05-01 4 Chief Business - Strategy Off bought 1,511 shares at $2.69 ($4,065)
2025-11-06 10-Q Quarterly Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading form10-q.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…